American International Group, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$0.42 - $0.74 $17,550 - $30,921	-41,786 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$0.76 - $1.32 $1,708 - $2,967	-2,248 Reduced 5.11%	41,786 $32,000
Q4 2017 Feb 09, 2018	BUY	$1.1 - $1.54 $9,504 - $13,305	8,640 Added 24.41%	44,034 $51,000
Q3 2017 Nov 09, 2017	BUY	$1.19 - $1.43 $42,118 - $50,613	35,394	35,394 $47,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.